Orchestra BioMed Holdings Statistics
Total Valuation
OBIO has a market cap or net worth of $261.59 million. The enterprise value is $170.45 million.
Important Dates
The next estimated earnings date is Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OBIO has 58.52 million shares outstanding. The number of shares has increased by 29.67% in one year.
| Current Share Class | 58.52M |
| Shares Outstanding | 58.52M |
| Shares Change (YoY) | +29.67% |
| Shares Change (QoQ) | +18.74% |
| Owned by Insiders (%) | 2.67% |
| Owned by Institutions (%) | 19.87% |
| Float | 32.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.80 |
| Forward PS | 133.58 |
| PB Ratio | 4.87 |
| P/TBV Ratio | 4.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.45, with a Debt / Equity ratio of 0.25.
| Current Ratio | 6.45 |
| Quick Ratio | 6.37 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -27.27 |
Financial Efficiency
Return on equity (ROE) is -109.41% and return on invested capital (ROIC) is -50.27%.
| Return on Equity (ROE) | -109.41% |
| Return on Assets (ROA) | -33.90% |
| Return on Invested Capital (ROIC) | -50.27% |
| Return on Capital Employed (ROCE) | -52.80% |
| Weighted Average Cost of Capital (WACC) | 7.65% |
| Revenue Per Employee | $389,326 |
| Profits Per Employee | -$615,756 |
| Employee Count | 86 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 0.79 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +58.51% in the last 52 weeks. The beta is 0.60, so OBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +58.51% |
| 50-Day Moving Average | 4.29 |
| 200-Day Moving Average | 3.71 |
| Relative Strength Index (RSI) | 53.71 |
| Average Volume (20 Days) | 167,435 |
Short Selling Information
The latest short interest is 957,939, so 1.64% of the outstanding shares have been sold short.
| Short Interest | 957,939 |
| Short Previous Month | 794,502 |
| Short % of Shares Out | 1.64% |
| Short % of Float | 2.95% |
| Short Ratio (days to cover) | 3.70 |
Income Statement
In the last 12 months, OBIO had revenue of $33.48 million and -$52.96 million in losses. Loss per share was -$1.11.
| Revenue | 33.48M |
| Gross Profit | 33.29M |
| Operating Income | -51.81M |
| Pretax Income | -52.70M |
| Net Income | -52.96M |
| EBITDA | -51.48M |
| EBIT | -51.81M |
| Loss Per Share | -$1.11 |
Full Income StatementBalance Sheet
The company has $106.51 million in cash and $15.96 million in debt, with a net cash position of $90.56 million or $1.55 per share.
| Cash & Cash Equivalents | 106.51M |
| Total Debt | 15.96M |
| Net Cash | 90.56M |
| Net Cash Per Share | $1.55 |
| Equity (Book Value) | 63.38M |
| Book Value Per Share | 0.94 |
| Working Capital | 91.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$48.96 million and capital expenditures -$489,000, giving a free cash flow of -$49.45 million.
| Operating Cash Flow | -48.96M |
| Capital Expenditures | -489,000 |
| Depreciation & Amortization | 327,000 |
| Net Borrowing | 20.00M |
| Free Cash Flow | -49.45M |
| FCF Per Share | -$0.85 |
Full Cash Flow StatementMargins
Gross margin is 99.43%, with operating and profit margins of -154.73% and -157.40%.
| Gross Margin | 99.43% |
| Operating Margin | -154.73% |
| Pretax Margin | -157.40% |
| Profit Margin | -157.40% |
| EBITDA Margin | -153.75% |
| EBIT Margin | -154.73% |
| FCF Margin | n/a |
Dividends & Yields
OBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.67% |
| Shareholder Yield | -29.67% |
| Earnings Yield | -20.29% |
| FCF Yield | -18.95% |
Analyst Forecast
The average price target for OBIO is $14.25, which is 218.79% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.25 |
| Price Target Difference | 218.79% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 27.66% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OBIO has an Altman Z-Score of -2.75 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.75 |
| Piotroski F-Score | 5 |
